These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14617759)

  • 21. Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with the fanconi anemia C gene after conditioning with low-dose irradiation.
    Kang EM; Hanazano Y; Frare P; Vanin EF; De Witte M; Metzger M; Liu JM; Tisdale JF
    Mol Ther; 2001 Jun; 3(6):911-9. PubMed ID: 11407905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow-derived cells exhibiting lung epithelial cell characteristics are enriched in vivo using methylguanine DNA methyltransferase-mediated drug resistance.
    Reese JS; Roth JC; Gerson SL
    Stem Cells; 2008 Mar; 26(3):675-81. PubMed ID: 18192231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo selection of human hematopoietic cells in a xenograft model using combined pharmacologic and genetic manipulations.
    Pollok KE; Hartwell JR; Braber A; Cooper RJ; Jansen M; Ragg S; Bailey BJ; Erickson LC; Kreklau EL; Williams DA
    Hum Gene Ther; 2003 Dec; 14(18):1703-14. PubMed ID: 14670122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival.
    Keil F; Prinz E; Moser K; Mannhalter C; Kalhs P; Worel N; Rabitsch W; Schulenburg A; Mitterbauer M; Greinix H
    Transplantation; 2003 Jul; 76(1):230-6. PubMed ID: 12865815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning and expression of canine O6-methylguanine-DNA methyltransferase in target cells, using gammaretroviral and lentiviral vectors.
    Zaboikin M; Srinivasakumar N; Zaboikina T; Schuening F
    Hum Gene Ther; 2004 Apr; 15(4):383-92. PubMed ID: 15053863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retroviral-mediated gene transduction of human alkyltransferase complementary DNA confers nitrosourea resistance to human hematopoietic progenitors.
    Allay JA; Koç ON; Davis BM; Gerson SL
    Clin Cancer Res; 1996 Aug; 2(8):1353-9. PubMed ID: 9816307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo protection of hematopoietic cells from alkylator-mediated DNA damage.
    Pollok KE
    Curr Hematol Rep; 2003 Jul; 2(4):341-7. PubMed ID: 12901332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrovirus-mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo.
    Moritz T; Mackay W; Glassner BJ; Williams DA; Samson L
    Cancer Res; 1995 Jun; 55(12):2608-14. PubMed ID: 7780976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards hematopoietic stem cell-mediated protection against infection with human immunodeficiency virus.
    Schambach A; Schiedlmeier B; Kühlcke K; Verstegen M; Margison GP; Li Z; Kamino K; Bohne J; Alexandrov A; Hermann FG; von Laer D; Baum C
    Gene Ther; 2006 Jul; 13(13):1037-47. PubMed ID: 16541120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved short-term engraftment of lentivirally versus gammaretrovirally transduced allogeneic canine repopulating cells.
    Neff T; Gerull S; Peterson LJ; Kiem HP
    J Gene Med; 2007 May; 9(5):357-61. PubMed ID: 17421055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A bicistronic SIN-lentiviral vector containing G156A MGMT allows selection and metabolic correction of hematopoietic protoporphyric cell lines.
    Richard E; Géronimi F; Lalanne M; Ged C; Redonnet-Vernhet I; Lamrissi-Garcia I; Gerson SL; de Verneuil H; Moreau-Gaudry F
    J Gene Med; 2003 Sep; 5(9):737-47. PubMed ID: 12950064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy for canine alpha-L-iduronidase deficiency: in utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of disease.
    Lutzko C; Omori F; Abrams-Ogg AC; Shull R; Li L; Lau K; Ruedy C; Nanji S; Gartley C; Dobson H; Foster R; Kruth S; Dubé ID
    Hum Gene Ther; 1999 Jun; 10(9):1521-32. PubMed ID: 10395377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo gene marking of rhesus macaque long-term repopulating hematopoietic cells using a VSV-G pseudotyped versus amphotropic oncoretroviral vector.
    Shi PA; De Angioletti M; Donahue RE; Notaro R; Luzzatto L; Dunbar CE
    J Gene Med; 2004 Apr; 6(4):367-73. PubMed ID: 15079811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. O6-methylguanine-DNA-methyltransferase (MGMT) gene therapy targeting haematopoietic stem cells: studies addressing safety issues.
    Sorg UR; Kleff V; Fanaei S; Schumann A; Moellmann M; Opalka B; Thomale J; Moritz T
    DNA Repair (Amst); 2007 Aug; 6(8):1197-209. PubMed ID: 17499560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retroviral vectors containing a variant dihydrofolate reductase gene for drug protection and in vivo selection of hematopoietic cells.
    Allay JA; Galipeau J; Blakley RL; Sorrentino BP
    Stem Cells; 1998; 16 Suppl 1():223-33. PubMed ID: 11012166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.
    Cowan KH; Moscow JA; Huang H; Zujewski JA; O'Shaughnessy J; Sorrentino B; Hines K; Carter C; Schneider E; Cusack G; Noone M; Dunbar C; Steinberg S; Wilson W; Goldspiel B; Read EJ; Leitman SF; McDonagh K; Chow C; Abati A; Chiang Y; Chang YN; Gottesman MM; Pastan I; Nienhuis A
    Clin Cancer Res; 1999 Jul; 5(7):1619-28. PubMed ID: 10430060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD34+ cell dose, conditioning regimen and prior chemotherapy: factors with significant impact on the early kinetics of donor chimerism after allogeneic hematopoietic cell transplantation.
    Mohr B; Koch R; Thiede C; Kroschinsky F; Ehninger G; Bornhäuser M
    Bone Marrow Transplant; 2004 Dec; 34(11):949-54. PubMed ID: 15489870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonal inventory screens uncover monoclonality following serial transplantation of MGMT P140K-transduced stem cells and dose-intense chemotherapy.
    Giordano FA; Sorg UR; Appelt JU; Lachmann N; Bleier S; Roeder I; Kleff V; Flasshove M; Zeller WJ; Allgayer H; von Kalle C; Fruehauf S; Moritz T; Laufs S
    Hum Gene Ther; 2011 Jun; 22(6):697-710. PubMed ID: 21319998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells.
    Briones J; Urbano-Ispizua A; Lawler M; Rozman C; Gardiner N; Marín P; Salgado C; Féliz P; McCann S; Montserrat E
    Exp Hematol; 1998 May; 26(5):415-20. PubMed ID: 9590658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.